Mus vs Namibia: Estimated antiretroviral therapy coverage among people living with HIV
Mus
36.0%
in 2025
Namibia
95.0%
in 2025
Mus rank
2nd
Namibia rank
5th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Mus
- Namibia
How they compare
Namibia currently reports 95.0% against 36.0% in Mus, a difference of 59.0%.
That makes Namibia's figure about 2.6 times Mus's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Namibia ahead.
Mus ranks 2nd and Namibia ranks 5th of 2 regions.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 11.7% | 8.8% | Namibia |
| 2010s | 20.5% | 59.4% | 38.9% | Namibia |
| 2020s | 30.7% | 90.2% | 59.5% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Mus or Namibia?
- Namibia, at 95.0% against 36.0% in Mus as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Mus and Namibia?
- 59.0%, with Namibia ahead.
- How many years of comparable data are there for Mus and Namibia?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Namibia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Mus ranks 2nd and Namibia ranks 5th of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.